{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:05:23Z","timestamp":1793829923909,"version":"4.6.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jconrel.2017.05.017","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T15:01:27Z","timestamp":1494860487000},"page":"130-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Aptamer-mediated gene therapy enhanced antitumor activity against human hepatocellular carcinoma in vitro and in vivo"],"prefix":"10.1016","volume":"258","author":[{"given":"Shuangli","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongbing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaozhi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Famin","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyun","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1509-4540","authenticated-orcid":false,"given":"Zhirong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.05.017_bb0005","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.cell.2006.05.030","article-title":"Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach","volume":"125","author":"Zender","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2017.05.017_bb0010","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"EL-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2017.05.017_bb0015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000330734","article-title":"Identification by differential tissue proteome analysis of talin-1 as a novel molecular marker of progression of hepatocellular carcinoma","volume":"80","author":"Kanamori","year":"2011","journal-title":"Oncology"},{"key":"10.1016\/j.jconrel.2017.05.017_bb0020","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0025","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s13277-011-0155-8","article-title":"Cancer stem cells and cancer therapy","volume":"32","author":"Soltanian","year":"2011","journal-title":"Tumour Biol."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0030","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","article-title":"PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer","volume":"275","author":"Li","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2017.05.017_bb0035","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ng0497-356","article-title":"Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers","volume":"15","author":"Steck","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1677\/erc.0.0070115","article-title":"PTEN, a unique tumor suppressor gene","volume":"7","author":"Dahia","year":"2000","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.jconrel.2017.05.017_bb0045","first-page":"7052","article-title":"Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary","volume":"60","author":"Sato","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0050","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/jcb.25159","article-title":"Oncogenic and therapeutic targeting of PTEN loss in bone malignancies","volume":"116","author":"Xi","year":"2015","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-2006-960171","article-title":"Genomics and signaling pathways in hepatocellular carcinoma","volume":"27","author":"Villanueva","year":"2007","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep.26369","article-title":"MicroRNA-216a\/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer","volume":"58","author":"Xia","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2017.05.017_bb0065","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s11095-006-9200-5","article-title":"Adenoviral gene delivery to solid tumors by recombinant silk-elastin like protein polymers","volume":"24","author":"Hatefi","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0070","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/mt.2011.112","article-title":"Tumor vascular targeted delivery of polymer-conjugated adenovirus vector for cancer gene therapy","volume":"19","author":"Yao","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0075","first-page":"985","article-title":"Protection of adenovirus from neutralizing antibody by cationic PEG derivative ionically linked to adenovirus","volume":"7","author":"Zeng","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.05.017_bb0080","first-page":"5039","article-title":"Mannan-modified Ad5-PTEN treatment combined with docetaxel improves the therapeutic effect in H22 tumor-bearing mice","volume":"7","author":"Liu","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.05.017_bb0085","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1158\/0008-5472.CAN-09-0654","article-title":"The emerging role of EpCAM in cancer and stem cell signaling","volume":"69","author":"Munz","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0090","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1038\/onc.2014.438","article-title":"Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM(+) AFP(+) hepatocellular carcinoma","volume":"34","author":"Zhao","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2017.05.017_bb0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2174\/13892002113149990010","article-title":"Aptamers as targeting delivery devices or anti-cancer drugs for fighting tumors","volume":"14","author":"Scaggiante","year":"2013","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0100","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1039\/c3tb20412j","article-title":"Selective delivery of an anticancer drug with aptamer-functionalized liposomes to breast cancer cells in vitro and in vivo","volume":"1","author":"Xing","year":"2013","journal-title":"J. Mater. Chem. B Mater. Biol. Med."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0105","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1002\/bit.24558","article-title":"AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery","volume":"109","author":"Aravind","year":"2012","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0110","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.1016\/j.biomaterials.2011.07.004","article-title":"Aptamer-functionalized PEGPLGA nanoparticles for enhanced anti-glioma drug delivery","volume":"32","author":"Guo","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.05.017_bb0115","doi-asserted-by":"crossref","first-page":"17356","DOI":"10.1073\/pnas.0809154105","article-title":"Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles","volume":"105","author":"Dhar","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0120","doi-asserted-by":"crossref","first-page":"5244","DOI":"10.1016\/j.biomaterials.2013.03.006","article-title":"Aptamer conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer","volume":"34","author":"Xu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.05.017_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1073\/pnas.0909611107","article-title":"DNA aptamer-micelle as an efficient detection\/delivery vehicle toward cancer cells","volume":"107","author":"Wu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0130","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1349-7006.2011.01897.x","article-title":"RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule","volume":"102","author":"Shigdar","year":"2011","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1021\/mp900151k","article-title":"Anionic liposomes increase the efficiency of adenovirus-mediated gene transfer to coxsackie-adenovirus receptor deficient cells","volume":"7","author":"Zhong","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.canlet.2016.10.003","article-title":"Enhanced growth inhibition of prostate cancer in vitro and in vivo by a recombinant adenovirus-mediated dual-aptamer modified drug delivery system","volume":"383","author":"Jing","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0145","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1093\/nar\/gkg599","article-title":"Vienna RNA secondary structure server","volume":"31","author":"Hofacker","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0150","first-page":"1925","article-title":"Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine","volume":"5","author":"Cao","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0155","first-page":"1083","article-title":"Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes","volume":"6","author":"Zhong","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.05.017_bb0160","first-page":"589","article-title":"Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay","volume":"48","author":"Alley","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0165","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1248\/bpb1978.2.350","article-title":"Drug-carrier property of albumin microspheres in chemotherapy. III. Effect of microsphere-entrapped 5-fluorouracil on Ehrlich ascites carcinoma in mice","volume":"2","author":"Sugibayashi","year":"1979","journal-title":"J. Pharmacobiodyn."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0170","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.4049\/jimmunol.174.11.7179","article-title":"Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein","volume":"174","author":"Sumida","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0175","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/JCM.41.11.5046-5052.2003","article-title":"Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors","volume":"41","author":"Sprangers","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0180","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ijpharm.2015.11.019","article-title":"GX1-mediated anionic liposomes carrying adenoviral vectors for enhanced inhibition of gastric cancer vascular endothelial cells","volume":"496","author":"Xiong","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0185","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/10430349950018021","article-title":"PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo","volume":"10","author":"O'Riordan","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2017.05.017_bb0190","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1038\/onc.2008.49","article-title":"Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors","volume":"27","author":"Steelman","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2017.05.017_bb0195","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejso.2010.12.003","article-title":"Clinical significance of tumor suppressor PTEN in colorectal carcinoma","volume":"37","author":"Hsu","year":"2011","journal-title":"Eur. J. Surg. Oncol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916311191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916311191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:40:37Z","timestamp":1770399637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916311191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":39,"alternative-id":["S0168365916311191"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.05.017","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aptamer-mediated gene therapy enhanced antitumor activity against human hepatocellular carcinoma in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}